Summary
Neonatal drug concentrations and neonate/mother concentration ratios are reported in 73 cases of elective Caesarean section and forceps deliveries where diazepam was used as an intravenous sleep-inducing agent. The various parameters were plotted against the injection-delivery interval and the correlation was tested using a non-parametric ranking method.
The concentration of diazepam in mixed arteriovenous umbilical cord blood was negatively correlated with the injection-delivery interval in the range of 55 to 810 seconds. Statistically significant positive correlations (p < 0.001) were found between the injection-delivery interval and the neonatal concentrations at 2 and 24 hours. The corresponding neonate/ther concentration ratios varied considerably, and were not so strongly correlated to the duration of antenatal drug transfer.
The results suggest that with a slowly eliminated agent like diazepam, the drug concentration in capillary blood obtained from the newborn a few hours after delivery gives a reasonably good indication of the fetal drug exposure. The transplacental passage of diazepam is rapid, with distribution equilibrium between mother and fetus being approached within 5 to 10 minutes after intravenous injection of the drug.
Similar content being viewed by others
References
Bakke, O.M.; Haram, K.; Lygre, T. and Wallern, G.: Comparison of the placental transfer of thiopental and diazepam in Caesarean section. European Journal of Clinical Pharmacology 21: 221–227 (1981).
Berlin, A.; Siwers, B.; Agurell, S.; Hiort, Å.; Sjöqvist, F. and Ström, S.: Determination of bioavailability of diazepam in various formulations from steady state plasma concentration data. Clinical Pharmacology and Therapeutics 13: 733–744 (1972).
Cree, J.E.; Meyer, J. and Hailey, D.M.: Diazepam in labour: Its metabolism and effect on the clinical condition and thermogenesis of the newborn. British Medical Journal 4: 251–255 (1973).
Datta, S. and Alper, M.H.: Anesthesia for Cesarean section. Anesthesiology 53: 142–160 (1980).
Finster, M. and Pedersen, H.: Placental transfer and fetal uptake of drugs. British Journal of Anaesthesia 51: 25S–28S (1979).
Finster, M.; Mark, L.C.; Morishima, H.O.; Moya, F.; Perel, J.M.; James, L.S. and Dayton, P.G.: Plasma thiopental concentrations in the newborn following delivery under thiopental-nitrous oxide anesthesia. American Journal of Obstetrics and Gynecology 95: 621–629 (1966).
Finster, M.; Morishima, H.O.; Mark, L.C.; Perel, J.M.; Dayton, P.G. and James, L.S.: Tissue thiopental concentrations in the fetus and newborn. Anesthesiology 36: 155–158 (1972).
Flowers, C.E.: Factors related to the placental transfer of thiopental in the hemochorial placenta. American Journal of Obstetrics and Gynecology 85: 646–656 (1963).
Gamble, J.A.S.; Moore, J.; Lamki, H. and Howard, P.J.: A study of plasma diazepam levels in mother and infant. British Journal of Obstetrics and Gynaecology 84: 588–591 (1977).
Green, T.P.; O’Dea, R.F. and Mirkin, B.L.: Determinants of drug disposition and effect in the fetus. Annual Review of Pharmacology and Toxicology 19: 285–322 (1979).
Goldstein, A.; Aronow, L. and Kaiman, S.M.: Principles of Drug Action, 2nd ed. (John Wiley and Sons, New York 1974).
Hamar, C. and Levy, G.: Serum protein binding of drugs and bilirubin in newborn infants and their mothers. Clinical Pharmacology and Therapeutics 28: 58–63 (1980).
Haram, K. and Bakke, O.M.: Diazepam as an induction agent for Caesarean section: A clinical and pharmacokinetic study of fetal drug exposure. British Journal of Obstetrics and Gynaecology 87: 506–512 (1980).
Haram, K.; Bakke, O.M.; Johnannessen, K.H. and Lund, T.: Transplacental passage of diazepam during labor: Influence of uterine contractions. Clinical Pharmacology and Therapeutics 24: 590–599 (1978).
Haram, K.; Bakke, O.M.; Sandvei, R. and Lund, T.: Foetal drug exposure following intravenous injection of diazepam immediately before breech delivery. Annales Chirurgicae et Gynaecologicae 68: 104–108 (1979).
Hillestad, L.; Hansen, T.; Melsom, H. and Drivenes, A.: Diazepam metabolism in normal man. I. Serum concentrations and clinical effects after intravenous, intramuscular, and oral administration. Clinical Pharmacology and Therapeutics 16: 479–484 (1974).
Kauffman, R.E.; Azarnoff, D.L. and Morris, J.A.: Placental transfer and fetal urinary excretion of gentamicin — comparison between an animal model and the human fetus; in Morselli et al. (Eds) Basic and Therapeutic Aspects of Perinatal Pharmacology, pp.75–82 (Raven Press, New York 1975).
Klotz, U.; Antonin, K.-H. and Bieck, P.R.: Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. Journal of Pharmacology and Experimental Therapeutics 199: 67–83 (1976).
Krauer, B. and Krauer, F.: Drug kinetics in pregnancy. Clinical Pharmacokinetics 2: 167–181 (1977).
Krauer, B.; Krauer, F, and Hytten, F.E.: Drug disposition and pharmacokinetics in the maternal-placental-fetal unit. Pharmacology and Therapeutics 10: 301–328 (1980).
Levy, G. and Hayton, W.L.: Pharmacokinetic aspects of placental drug transfer; in Boreus (Ed) Fetal Pharmacology, pp.29–39 (Raven Press, New York 1973).
Magno, R.; Selstam, U. and Karlsson, K.: Anesthesia for Cesarean section. II. Effects of the induction-delivery interval on the respiratory adaptation of the newborn in elective Cesarean section. Acta Anaesthesiologica Scandinavica 19: 250–259 (1975).
Mandelli, M.; Morselli, P.L.; Nordio, S.; Pardi, G.; Principi, N.; Sereni, F. and Tognoni, G.: Placental transfer of diazepam and its disposition in the newborn. Clinical Pharmacology and Therapeutics 17: 564–572 (1975).
Mirkin, B.L. and Singh, S.: Placental transfer of pharmacologically active molecules; in Mirkin (Ed) Perinatal Pharmacology and Therapeutics, pp.1–69 (Academic Press, New York 1976).
Moore, R.G. and McBride, W.G.: The disposition kinetics of diazepam in pregnant women at parturition. European Journal of Clinical Pharmacology 13: 275–284 (1978).
Morselli, P.L.; Franco-Morselli, R. and Bossi, L.: Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. Clinical Pharmacokinetics 5: 485–527 (1980).
Moya, F. and Thorndike, V.: Passage of drugs across the placenta. American Journal of Obstetrics and Gynecology 84: 1778–1798 (1962).
Nishimura, H.: Comparative study on maternal-embryonic transfer of drugs in man and laboratory animals; in Boreus (Ed) Fetal Pharmacology, pp.47–53 (Raven Press, New York 1973).
Price, H.L.; Kovnat, P.J.; Safer, J.N.; Conner, E.H. and Price, M.L.: The uptake of thiopental by body tissues and its relation to the duration of narcosis. Clinical Pharmacology and Therapeutics 1: 16–22 (1960).
Rutherford, D.M.; Okoko, A. and Tyrer, P.J.: Plasma concentrations of diazepam and desmethyldiazepam during chronic diazepam therapy. British Journal of Clinical Pharmacology 6: 69–73 (1978).
Scher, J.; Hailey, D.M. and Beard, R.W.: The effects of diazepam on the fetus. Journal of Obstetrics and Gynaecology of the British Commonwealth 79: 635–638 (1972).
Sereni, F.: The need for further data. Clinical Pharmacology and Therapeutics 14: 662–665 (1973).
Speight, A.N.P.: Floppy-infant syndrome and maternal diazepam and/or nitrazepam. Lancet 2: 878 (1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bakke, O.M., Haram, K. Time-course of Transplacental Passage of Diazepam. Clin Pharmacokinet 7, 353–362 (1982). https://doi.org/10.2165/00003088-198207040-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198207040-00005